National strategies for viral hepatitis B, C and hepatocellular carcinoma in Taiwan

International Hepatology Communications

Volumn 5, Issue 1, 1996, Pages 43-52

  Sung, Juei Low ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Sun Yat Sen Hospital 125   (Taiwan)

Author keywords

hepatitis B; hepatitis C; hepatocellular carcinoma; vaccination

Indexed keywords

CONFERENCE PAPER; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TAIWAN; VACCINATION;

EID: 0029894992     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(96)82010-X     Document Type: Conference Paper

References (20)

1. Sung JL, Chen DS. Hepatitis B surface antigen and antibody in liver disease in Taiwan. Proc 5th Asian Pacific Congress of Gastroenterology, Singapore, 1976; 265-269.
2. Sung JL, Chen DS, Lain MY, Yu JY, Wang TH, Wang CY, Lee CY, Chen SH, Ko TM. Epidemiological study on hepatitis B virus infection in Taiwan. Chinese J Gastroenterol 1984; 1: 1-9.
3. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979; 3: 237-241.
4. Liaw YF, Chen DS, Wang TH, Sung JL. The study of chronic aggressive hepatitis. Proc International Symposium on Hepatitis in Taipei. Taipei, 1974; 133-136.
5. Yang PM, Chen DS, Lai MY, Huang GT, Lin JT, Sheu JC, Hsu HC, Sung JL. Clinicopathological studies of asymptomatic HBsAg carriers: With special emphasis on carriers older than 40 years. Hepato-gastroenterol 1987; 34: 251-254.
6. Sung JL. Chronic hepatitis and cirrhosis of liver in Taiwan. In: Harada T, ed. Hepatology: Recent Topics. Tokyo: Nihon Igakkan, 1989; 1-6.
7. Beasley RP, Hwang LY, Lee CY, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immunoglobulin and hepatitis B vaccine. Lancet 1983; 2: 1099-1102.
8. Lo KJ, Tsai YT, Lee SD, WTC, Wang JY, Chen GH, Yeh CL, Chiang BN, Yeh SH, Goudean A, Consaget P, Tong MJ. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985; 152: 817-822.
9. Chen DS, Chen Hsu HM, Sung JL, Hsu TC, Hsu ST, Kup YT, Lo KJ, Shih YT. The Hepatitis Steering Committee and The Hepatitis Control Committee: Control of hepatitis B virus Infection in a Hyperendemic area: A mass immunoprophylaxis program in Taiwan. In: Viral Hepatitis and Liver disease. Alan R Liss Inc, 1988: 971-976.
10. Hsu HM, Chen DS, Chuang CH, Lu JCF, Jow DM, Lee CC, Lu HC, Cheng SH, Wang YF, Wang CC, Lo KJ, Shih CJ, Sung JL. Efficacy of a mass hepatitis B vaccination program in Taiwan: Studies on 3446 infants of hepatitis B surface antigen-carrier mothers. J Am Med Assoc 1988; 260: 2231-2235.
11. Sung JL. Control of hepatitis B in Taiwan. In: Sung JL, Chen DS, eds. Viral Hepatitis and Hepatocellular Carcinoma. Hong Kong: Excerpta Medica, 1988: 435-448.
12. Lo KJ, Lee SD, Tsai YT, WTC, Chan CY, Chen GH, Yeh CL. Long-term immunogenecity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology 1988; 8: 1647-1650.
13. Lee CY, Huang LM, Chang NH, Hsu CY, Wu SJ, Sung JL. The protective efficacy of recombinant hepatitis B vaccine in infants of HBeAg-positive HBsAg carrier mothers. Pediatr Infect Dis 1991; 10: 299-303.
14. Chen DS, Kuo G, Sung JL, Lai NY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton N. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience. J Infect Dis 1990; 162: 817-822.
15. Wang TH, Wang JT, Lin JT, Sheu JC, Sung JL, Cen DS. A prospective study of post-transfusion hepatitis in Taiwan. J Hepatol 1991; 13: 38-43.
16. Wang JT, Wang TH, Lin JT, Lee CZ, Sheu JC, Chen DS. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol 1995; 10: 454-458.
17. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond) 1991; 350: 429-431.
18. Tseng JT, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: Five years after a mass hepatitis B vaccination program. J Med Virol 1991; 34: 96-99.
19. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris C. Mutational hotspots in the p53 gene in human hepatocellular carcinoma. Nature (Lond) 1991; 350: 427-428.
20. Sheu JC, Huang GT, Lee PH, Chung JC, Chou HC, Lai MY, Wang JT, Lee HS, Shih LN, Yang PM, Wang TH, Chen DS. Mutation of p53 gene in hepatocellular carcinoma. Cancer Res 1992; 52: 6098-6100.